Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

Clinical trial NCT05372991 · COMPLETED

Trial details

NCT number: NCT05372991
Sponsor: Cloudbreak Therapeutics, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myopia, Progressive

Start date: 2022-07-20
Primary completion: 2023-01-18
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.